TY - JOUR
T1 - Recommendations for the use of sensor-augmented pumps with predictive low-glucose suspend features in children
T2 - The importance of education
AU - Scaramuzza, Andrea E.
AU - Arnaldi, Claudia
AU - Cherubini, Valentino
AU - Piccinno, Elvira
AU - Rabbone, Ivana
AU - Toni, Sonia
AU - Tumini, Stefano
AU - Candela, Gilberto
AU - Cipriano, Paola
AU - Ferrito, Lucia
AU - Lenzi, Lorenzo
AU - Tinti, Davide
AU - Cohen, Ohad
AU - Lombardo, Fortunato
N1 - Publisher Copyright:
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
PY - 2017/12
Y1 - 2017/12
N2 - Abstract: Sensor-augmented pumps, which consist of a pump and a continuous glucose monitoring system, offer considerable therapeutic opportunities, despite requiring close attention in the early phase of their use. The aim of this paper is to provide recommendations on the use of a predictive low glucose management (PLGM) system (Minimed 640G™, Medtronic, Northridge, CA, USA) in adolescents with type 1 diabetes either at the start of therapy or during follow-up. Sound clinical recommendations on PLGM are of increasing importance since several recent papers have reported significant clinical improvements in patients with PLGM, especially in adults. These recommendations are based on the experience of a group of pediatric endocrinologists who collaborated to closely and intensively study the on-boarding of adolescent patients with type 1 diabetes on automated systems to gain first-hand experience and peer-to-peer insights in a unique free-living environment. The suggestions provided here are indicative, so can be adapted to the individual realities and experiences of different diabetes centers. However, we believe that close adherence to the proposed scheme is likely to increase the chances of improving the clinical and metabolic outcomes of patients treated with this therapy.
AB - Abstract: Sensor-augmented pumps, which consist of a pump and a continuous glucose monitoring system, offer considerable therapeutic opportunities, despite requiring close attention in the early phase of their use. The aim of this paper is to provide recommendations on the use of a predictive low glucose management (PLGM) system (Minimed 640G™, Medtronic, Northridge, CA, USA) in adolescents with type 1 diabetes either at the start of therapy or during follow-up. Sound clinical recommendations on PLGM are of increasing importance since several recent papers have reported significant clinical improvements in patients with PLGM, especially in adults. These recommendations are based on the experience of a group of pediatric endocrinologists who collaborated to closely and intensively study the on-boarding of adolescent patients with type 1 diabetes on automated systems to gain first-hand experience and peer-to-peer insights in a unique free-living environment. The suggestions provided here are indicative, so can be adapted to the individual realities and experiences of different diabetes centers. However, we believe that close adherence to the proposed scheme is likely to increase the chances of improving the clinical and metabolic outcomes of patients treated with this therapy.
KW - continuous glucose monitoring
KW - continuous subcutaneous insulin infusion
KW - insulin pump therapy
KW - predictive low-glucose management
KW - predictive low-glucose suspend
KW - recommendations
KW - sensor augmented pump
UR - http://www.scopus.com/inward/record.url?scp=85026359178&partnerID=8YFLogxK
U2 - 10.1111/pedi.12503
DO - 10.1111/pedi.12503
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 28101899
AN - SCOPUS:85026359178
SN - 1399-543X
VL - 18
SP - 883
EP - 889
JO - Pediatric Diabetes
JF - Pediatric Diabetes
IS - 8
ER -